Castellsagué X, Menéndez C, Loscertales M P, Kornegay J R, dos Santos F, Gómez-Olivé F X, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch F X, Alonso P
Lancet. 2001 Oct 27;358(9291):1429-30. doi: 10.1016/S0140-6736(01)06523-0.
We studied the genotype distribution of cervical human papillomavirus (HPV) infections in an age-stratified sample of 262 women in Mozambique using the PGMYO9-PGMY11 primer system in a reverse line-blot strip-based assay with high sensitivity in type-specific amplification. Despite the low precision of the estimates, we found that HPV-16 was not the dominant type. Instead, HPV 35 was the most commonly identified genotype among HPV-positive women (16/96 [17%]) and women with cervical neoplasia (7/23 [30%]). Certain genotypes might have been under-detected in previous studies, and type-specific HPV distributions might vary across populations. Therefore, the estimated proportion of cervical neoplasia that could be prevented by an HPV-16-based vaccine could be lower than expected.
我们使用PGMYO9-PGMY11引物系统,通过基于反向线印迹条带的检测方法,在莫桑比克262名按年龄分层的女性样本中研究了宫颈人乳头瘤病毒(HPV)感染的基因型分布,该检测方法在型特异性扩增方面具有高灵敏度。尽管估计精度较低,但我们发现HPV-16并非主要类型。相反,HPV 35是HPV阳性女性(16/96 [17%])和患有宫颈肿瘤的女性(7/23 [30%])中最常鉴定出的基因型。某些基因型在先前研究中可能未被充分检测到,并且型特异性HPV分布可能因人群而异。因此,基于HPV-16的疫苗可预防的宫颈肿瘤估计比例可能低于预期。